A retrospective real world study presenting clinical trial representativeness and treatment intensity in a sample of women with early-stage breast cancer
Latest Information Update: 10 Jul 2021
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary) ; Doxorubicin (Primary) ; Paclitaxel (Primary) ; Pertuzumab (Primary) ; Trastuzumab (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 10 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology